Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. | 373,295 | reported | 05 Mar 2026 | tx 42+3,281,830−1,034,026 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Mar 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 248,865 | 0.00 USD | |
| 05 Mar 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 373,295 | 0.00 USD | deriv |
| 02 Mar 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 29,282 | 14.47 USD | |
| 02 Feb 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 15,500 | 14.69 USD | |
| 15 Jan 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 197,153 | 7.57 USD | |
| 15 Jan 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 136,193 | 13.58 USD | |
| 16 Jan 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 2,847 | 7.57 USD | |
| 16 Jan 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 1,995 | 13.89 USD | |
| 15 Jan 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 197,153 | 0.00 USD | deriv |
| 16 Jan 2026 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 2,847 | 0.00 USD | deriv |
| 06 Jan 2026 | SALE | Amylyx Pharmaceuticals, Inc. | 7,715 | 11.09 USD | |
| 30 Sept 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 29,775 | 14.37 USD | |
| 30 Sept 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 200 | 15.01 USD | |
| 31 Mar 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 21,490 | 3.46 USD | |
| 06 Mar 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 180,118 | 0.00 USD | |
| 06 Mar 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 270,177 | 0.00 USD | deriv |
| 03 Mar 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 4,595 | 3.15 USD | |
| 05 Feb 2025 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 36,310 | 1.57 USD | |
| 05 Feb 2025 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 36,310 | 0.00 USD | deriv |
| 03 Feb 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 11,855 | 3.47 USD | |
| 06 Jan 2025 | SALE | Amylyx Pharmaceuticals, Inc. | 7,471 | 4.04 USD | |
| 04 Nov 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 63,690 | 1.57 USD | |
| 04 Nov 2024 | EXERCISE | Amylyx Pharmaceuticals, Inc. | 63,690 | 0.00 USD | deriv |
| 30 Sept 2024 | SALE | Amylyx Pharmaceuticals, Inc. | 18,589 | 3.20 USD | |
| 16 Apr 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 179,850 | 0.00 USD |